Add BrightSurf on Google Email

Barrow researchers make breakthrough on immune system and brain tumors

Researchers at Barrow Neurological Institute and Arizona State University have made a breakthrough in understanding why brain tumors are difficult to treat. The study reveals that the immune system behaves differently in different regions of the brain, including tumors, leading to potential limitations in effective treatment.

SourceSt. Joseph's Hospital and Medical Center·JournalCancer Management and Research·DateSep 26, 2012

People with allergies may have lower risk of brain tumors

A new study found that individuals with allergies had a significantly lower risk of developing glioma, a type of brain tumor. Women were more likely to benefit from this reduced risk, with those testing positive for elevated allergen-specific IgE experiencing a 54% decrease in glioblastoma risk.

SourceOhio State University·JournalJNCI Journal of the National Cancer Institute·DateAug 3, 2012

Pediatric tumors traced to stem cells in developing brain​​

Scientists at Washington University School of Medicine found that stem cells from a specific part of the developing brain contribute to brain tumors caused by neurofibromatosis type 1. The study suggests that understanding the unique characteristics of these stem cells may lead to more effective treatments for pediatric brain tumors.

SourceWashU Medicine·JournalCancer Cell·DateJul 9, 2012

Genetic markers hope for new brain tumor treatments

Researchers at the University of Nottingham have discovered three sets of genetic markers that could improve diagnosis and treatment outcomes for children with a rare type of brain tumor. The study found distinct genetic signatures for each sub-type of tumor, which may lead to more effective tools for predicting patient outcomes.

SourceUniversity of Nottingham·JournalThe Lancet Oncology·DateJun 15, 2012

Modeling the demise of migrating brain tumor cells

A theoretical model simulates brain tumor cell evolution under treatment, revealing that peripheral cells need to be targeted. The model suggests enhancing TTF treatment by applying specific frequencies, leading to increased plasma membrane permeability and cancer cell demise.

SourceSpringer·JournalThe European Physical Journal E·DateJun 6, 2012

Research yields new clues to how brain cancer cells migrate and invade

Researchers have discovered that the NKCC1 protein may hold key to understanding how glioblastoma, the deadliest type of brain cancer, moves and invades healthy brain tissue. Blocking NKCC1 with a cheap FDA-approved drug slows movement of glioblastoma cells, suggesting a potential new approach to treat this aggressive cancer.

SourcePLOS·JournalPLOS Biology·DateMay 1, 2012

How does the immune system fight off threats to the brain? New research yields fresh insight

Researchers have discovered that immune cells in the brain use a two-tier approach to combat infections, sending signals to neighboring cells while focusing their attack on infected cells. This finding may help researchers develop new treatments for brain tumors and autoimmune diseases.

SourceMichigan Medicine - University of Michigan·JournalProceedings of the National Academy of Sciences·DateApr 30, 2012

Development of the glial cell revealed

A team of researchers has identified a novel transcripitonal cascade that controls gliogenesis, the process by which glial cells are generated from neural stem cells. This discovery provides new insights into how glial cells support neuronal function and are implicated in neurological disorders such as Retts Syndrome, ALS, and Multiple...

SourceBaylor College of Medicine·JournalNeuron·DateApr 11, 2012

Grant to fuel baking soda cancer therapy research

The University of Arizona has received a $2 million grant from the National Institutes of Health to develop an innovative magnetic resonance imaging method for measuring pH levels in tumors. This technique aims to personalize cancer treatments, such as baking soda therapy, and predict their effectiveness before treatment begins.

PET tracer changes management plan for brain tumor patients

Imaging amino acid transporters with PET/CT has significantly altered management plans for 41% of patients with brain tumors, according to research. The imaging modality has improved detection of primary and recurrent high- and low-grade brain tumors, leading to changes in treatment from 'watch and wait' to chemotherapy or vice versa.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateMar 1, 2012

A thought-provoking new therapeutic target for brain cancer?

Glioblastoma multiforme (GBM) is a highly aggressive brain tumor resistant to current therapies. Researchers at the University of California, San Francisco, have identified PDGFR-alpha and SULF2 as potential therapeutic targets for GBM treatment. Knocking down SULF2 expression decreased cell growth in human GBM cell lines.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 1, 2012

Rigged to explode?

Researchers found a strong link between an inherited TP53 gene mutation and chromothripsis, a condition where chromosomes shatter and reassemble incorrectly. This discovery has significant implications for diagnosis and treatment, as patients with the mutation may be at high risk of developing certain types of cancer.

How brain tumors invade

Researchers identified a key protein mutation that enables brain tumors to invade healthy brain tissue. Excessive epidermal growth factor receptor (EGFR) signals trigger the production of GBP1, rendering tumors more invasive and allowing them to spread into surrounding tissue.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateDec 12, 2011

Enhanced treatment of brain tumors

A new treatment combination of radiation therapy and LY2109761 blocks TGF-β signaling pathways, slowing down tumor cell self-renewal and growth. This combination therapy improved outcomes in animal models and has the potential to delay glioblastoma progression in patients.

SourceHelmholtz Association·JournalCancer Research·DateNov 23, 2011

Metabolic protein plays unexpected role in tumor cell formation and growth

A team of researchers at the University of Texas MD Anderson Cancer Center found that pyruvate kinase M2 (PKM2) has an unexpected role in regulating cell proliferation and tumor formation in brain cancer. PKM2's ability to bind to beta-catenin in the cell nucleus is essential for its function, and its levels are correlated with brain t...